Mark S. Minkes

2.2k citations
10 papers · 1.8k indexed · 1 hit paper · h-index 10
Topics
Inflammatory mediators and NSAID effects (9 papers)Antiplatelet Therapy and Cardiovascular Diseases (6 papers)Eicosanoids and Hypertension Pharmacology (4 papers)
Partner nations
United States

In The Last Decade

Mark S. Minkes

10 papers receiving 1.6k citations

Hit Papers

Triene prostaglandins: Prostacyclin and thromboxane biosy...19792026199420101979200400600

Peers

Mark S. Minkes
Comparison fields: 5 of 97
  • Pharmacology 709
  • Biochemistry 624
  • Nutrition and Dietetics 601
  • Cardiology and Cardiovascular Medicine 366
  • Molecular Biology 363
Replace Melvin J. Silver with:
Melvin J. Silver United States
R.J. Gryglewski Poland
Reyadh Redha United States
Lauren M. Cagen United States
Evelyne Véricel France
Angela Wyche United States
Norberto A. Terragno United States
Carol M. Ingerman United States
N Stanford United States
Linda Davis United States
Mark S. Minkes relative to Melvin J. Silver United States Melvin J. Silver's profile →
Citations per field
00.5×
Melvin J. Silver · 1×
Citations per year

Countries citing papers authored by Mark S. Minkes

Since Specialization
Citations

This map shows the geographic impact of Mark S. Minkes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark S. Minkes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark S. Minkes more than expected).

Fields of papers citing papers by Mark S. Minkes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark S. Minkes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark S. Minkes. The network helps show where Mark S. Minkes may publish in the future.

Co-authorship network of co-authors of Mark S. Minkes

This figure shows the co-authorship network connecting the top 25 collaborators of Mark S. Minkes. A scholar is included among the top collaborators of Mark S. Minkes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark S. Minkes. Mark S. Minkes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
#WorkIndexed citations
1 21
2
Triene prostaglandins: Prostacyclin and thromboxane biosynthesis and unique biological propertiesbreakdown →
623
3 172
4 39
5 79
6 81
7 234
8 315
9 163
10 55

About Mark S. Minkes

Mark S. Minkes is a scholar working on Biochemistry, Pharmacology and Cardiology and Cardiovascular Medicine, having authored 10 papers that have together received 1.8k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (9 papers), Antiplatelet Therapy and Cardiovascular Diseases (6 papers) and Eicosanoids and Hypertension Pharmacology (4 papers). The work is most often cited by research in Biochemistry (624 citations), Pharmacology (709 citations) and Nutrition and Dietetics (601 citations). Mark S. Minkes has collaborated with scholars based in United States. Frequent co-authors include Philip Needleman, Amiram Raz, James A. Ferrendelli, Howard Sprecher, A Raz, J. R. Douglas, P Needleman, N Stanford, Philip W. Majerus and Peter C. Isakson. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026